Health ❯Pharmaceuticals

Weight Loss

Weight Loss Pharmaceuticals Clinical Trials Drug Development Drug Development Drug Pricing Stock Performance Marketing Strategies FDA FDA

FDA Ends GLP-1 Drug Shortages, Triggering New Pricing and Coverage Moves

Novo Nordisk and Cigna introduce temporary discounts and copay caps as compounded semaglutide distribution ceases under new FDA regulations.

Novo Nordisk Seeks FDA Approval as Eli Lilly's Weight-Loss Pill Advances

Widespread Use of Weight-Loss Drugs Redefines Health, Beauty, and Access

Roche and Zealand Partner in $5.3 Billion Deal for Obesity Drug Development

Eli Lilly Targets Unapproved Weight-Loss Drugs with New Ad Campaign